Systemic delivery of Ad-omentin exerted beneficial effects on the pulmonary endothelium by limiting the pulmonary inflammatory response and endothelial barrier injury in murine models of ARDS. This evidence concerns the gene ITLN1 and acute respiratory distress syndrome.